Evidence Supports No Expectation of Success for CRISPR-Cas in Eukaryotic Cells Richard ChinnSeptember 10, 2018
Burden of Proving a Real Party-in-Interest in IPR. An Existential Question? Richard ChinnSeptember 7, 2018
Without Sufficient Structural Support, Functional Claim Elements Don’t Stand Up Eric MyersAugust 16, 2018
Conjunction Junction, What's Your Function? Ex Parte Jung De-Designated and Removed From List of Informative Decisions Richard ChinnAugust 8, 2018
4th European Global Pharma IP Summit of the International Intellectual Property Law Association features Dr. Grüneberg among speakers Eric MyersJune 29, 2018
PTO Memo Advises on Subject Matter Eligibility That Application of a Natural Relationship Satisfied Step 2A of Alice Test Richard ChinnJune 14, 2018
Arguments in Reply Brief Are Not Limited to Designated New Grounds of Rejection Richard ChinnJune 12, 2018
Public Disclosure of a Spinal Alignment Procedure is Not Necessarily Publicly Accessible Richard ChinnJune 12, 2018
